The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Vaccine Contract Manufacturing market was valued at US$ 1731.5 million in 2023 and is anticipated to reach US$ 2558.5 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Vaccine Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Contract Manufacturing.
Report Scope
The Vaccine Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Diosynth
- Emergent BioSolutions
- Goodwin Biotechnology
- Bavarian Nordic
- Soligenix Inc
- Catalent Biologics
Segment by Type
- Fill-Finish
- Bulk Product
Segment by Application
- Pharmaceutical Companies
- Biotech Companies
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fill-Finish
1.2.3 Bulk Product
1.3 Market by Application
1.3.1 Global Vaccine Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Contract Manufacturing Market Perspective (2019-2030)
2.2 Vaccine Contract Manufacturing Growth Trends by Region
2.2.1 Global Vaccine Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Vaccine Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Vaccine Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Vaccine Contract Manufacturing Market Dynamics
2.3.1 Vaccine Contract Manufacturing Industry Trends
2.3.2 Vaccine Contract Manufacturing Market Drivers
2.3.3 Vaccine Contract Manufacturing Market Challenges
2.3.4 Vaccine Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Contract Manufacturing Players by Revenue
3.1.1 Global Top Vaccine Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Vaccine Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Contract Manufacturing Revenue
3.4 Global Vaccine Contract Manufacturing Market Concentration Ratio
3.4.1 Global Vaccine Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Contract Manufacturing Revenue in 2023
3.5 Vaccine Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Vaccine Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Vaccine Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Contract Manufacturing Breakdown Data by Type
4.1 Global Vaccine Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Vaccine Contract Manufacturing Breakdown Data by Application
5.1 Global Vaccine Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Vaccine Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Vaccine Contract Manufacturing Market Size (2019-2030)
6.2 North America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Contract Manufacturing Market Size (2019-2030)
7.2 Europe Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Vaccine Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Vaccine Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Vaccine Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Vaccine Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Vaccine Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Vaccine Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Diosynth
11.1.1 Diosynth Company Detail
11.1.2 Diosynth Business Overview
11.1.3 Diosynth Vaccine Contract Manufacturing Introduction
11.1.4 Diosynth Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.1.5 Diosynth Recent Development
11.2 Emergent BioSolutions
11.2.1 Emergent BioSolutions Company Detail
11.2.2 Emergent BioSolutions Business Overview
11.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Introduction
11.2.4 Emergent BioSolutions Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.2.5 Emergent BioSolutions Recent Development
11.3 Goodwin Biotechnology
11.3.1 Goodwin Biotechnology Company Detail
11.3.2 Goodwin Biotechnology Business Overview
11.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Introduction
11.3.4 Goodwin Biotechnology Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.3.5 Goodwin Biotechnology Recent Development
11.4 Bavarian Nordic
11.4.1 Bavarian Nordic Company Detail
11.4.2 Bavarian Nordic Business Overview
11.4.3 Bavarian Nordic Vaccine Contract Manufacturing Introduction
11.4.4 Bavarian Nordic Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.4.5 Bavarian Nordic Recent Development
11.5 Soligenix Inc
11.5.1 Soligenix Inc Company Detail
11.5.2 Soligenix Inc Business Overview
11.5.3 Soligenix Inc Vaccine Contract Manufacturing Introduction
11.5.4 Soligenix Inc Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.5.5 Soligenix Inc Recent Development
11.6 Catalent Biologics
11.6.1 Catalent Biologics Company Detail
11.6.2 Catalent Biologics Business Overview
11.6.3 Catalent Biologics Vaccine Contract Manufacturing Introduction
11.6.4 Catalent Biologics Revenue in Vaccine Contract Manufacturing Business (2019-2024)
11.6.5 Catalent Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
